The Effects of Estrogen in the Glucoregulatory Response to Exercise in Type 1 Diabetes
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INTRODUCTION

Regular exercise has shown to benefit the health of individuals with type 1
diabetes mellitus (T1DM). However, a barrier to regular exercise for this
population is the fear of low blood glucose (BG) levels, also known as
hypoglycemia1. Hypoglycemia can result in short and long-term side-effects,
such as recurring loss of consciousness or in severe cases death.
In non-diabetics, sex-related differences in fuel selection during exercise
are well established. Women shift towards using fats as fuel whereas men rely
mostly on sugars (i.e., carbohydrates) for energy production2. Exercise during
the luteal phase of the female menstrual cycle, where estrogen levels are
elevated, has shown to promote fat utilization3.
For women with T1DM, exercise during elevated estrogen levels may
potentially provide a protective mechanism against hypoglycemia as energy
sources such as glycogen (i.e., stored sugar) may be preserved. This may
reduce the need for the body to replete energy from the blood post-exercise,
thereby keeping BG levels balanced.

PURPOSE

The purpose of this study was to investigate the effects of exercise during
elevated estrogen levels on the expression of prominent gluconeogenic
enzymes, Phosphoenolpyruvate Carboxykinase (PEPCK) and Glucose 6phosphatase (G6Pase), in T1DM female livers.

METHODS

Animals:
• 4 groups of rats were used in this study. 5 control (non-T1DM)
exercise males (CXM), 5 control exercise females (CXF), 5 T1DM
exercise males (DXM), and 5 T1DM exercise females (DXF)
Diabetes induction:
• Daily STZ injections of 20 mg/kg were administered over one week
until blood glucose ≥18 mmol/L
• A subcutaneous insulin pellet was implanted to maintain BG at an
intended range of 4-8 mmol/L (2 units/day)
Exercise training protocol:
• Exercise training consisted of 1 hour of running on a motorized
treadmill (18-25m/min on a 6% gradient, ~75 V02max) for 4
consecutive days, where day 1 = diestrus (low estrogen) and day 4 =
proestrus (high estrogen)
Experimental measures:
• BG measurements were taken at 0-, 30-, and 60-mins (exercise), and
at 90 and 120-mins (recovery). Following the final training bout, rats
were euthanized, and liver tissues were removed. Western blot
analysis was conducted for PEPCK and G6Pase protein content.

RESULTS

SUMMARY

A

• The normal glucose counterregulatory response to
exercise is impaired in both male and female T1DM
rodents, resulting in a reduction of BG levels at the
onset of exercise

B

• Female T1DM BG levels during the final bout of
exercise (day 4) did not remain optimal compared to
male T1DM BG despite elevated estrogen levels
• However, female T1DM rodents had a greater postexercise BG recovery compared to male T1DM rodents
Figure 1: (A) Mean blood glucose data (mmol/L) from days 1-3 are presented together. All data are presented as
mean ± SEM. * denotes significance. (P < 0.0001) between diabetic and control females (DXF and CXF,
respectively). i denotes significance within control males (CXM) (P < 0.0001) and ii denotes significance within
CXF (P < 0.01). iii denotes significance within DXF (P < 0.05). DXM (diabetic males) had no significant
changes or differences.
Figure 1: (B) Mean blood glucose (mM) from day 4 exercise. All data are presented as mean ± SEM. * denoted
significance at t = 30 minutes (P < 0.05), ** denotes significance (P < 0.05) between starting and ending blood
glucose in control females and males (CXF and CXM, respectively) *** denotes significance (P < 0.05) between
30 to 60 minutes in diabetic females (DXF). There were no differences in blood glucose between CXM and
diabetic males (DXM).
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B

• PEPCK (?) and G6Pase appear to be elevated in female
compared to male T1DM rodents, as well as compared
to control rodents (pre-analysis/normalization)
• These findings suggest that while there was a decrease
in BG during exercise in T1DM females, they were
able to counteract this effect more successfully than
T1DM males. This enhanced BG recovery may be due
to an increased protein content of important
gluconeogenic enzymes in female T1DM livers which
may help elevate BG at a faster rate compared to
T1DM males
• Whether these differences in protein content are due to
estrogen signaling is still unknown
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FUNDING
Figure 2: (A) Liver PEPCK and (B) G6Pase protein content in arbitrary units following 4 days of aerobic exercise

